Anzeige
Mehr »
Freitag, 13.02.2026 - Börsentäglich über 12.000 News
Die Kommerzialisierung der räumlichen Intelligenz in Billionen-Märkten beginnt jetzt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
445 Leser
Artikel bewerten:
(2)

Children's Health Foundation: Pioneers in Pediatrics

Board member Drew Neville and the rest of the team at Children's Health Foundation of Oklahoma garner support and resources for crucial pediatric research that benefits children across the state.

OKLAHOMA CITY, OKLAHOMA / ACCESSWIRE / December 20, 2024 / Thousands of children throughout Oklahoma are facing pediatric diseases that impact their daily lives. The Children's Health Foundation of Oklahoma (CHF) was founded to support sick children and their families through funding research, education, and care across all of Oklahoma's 77 counties. Since 1982, the organization has raised more than $161 million for patients, and 75% of the state's pediatricians are currently supported by CHF.

This impact is what originally attracted Drew Neville to join the organization's board of directors in the late 1980s. Currently of counsel for McAfee & Taft, Neville has worked as a trial lawyer for over 50 years. He brings this unique mindset to the work he does on CHF's board, which has contributed to 36 endowed chairs in 13 different pediatric specialties-from oncology and neonatology to genealogy and pulmonology.

"Our board is very driven. You don't get to attend meetings and have a glass of wine and then go home," laughs Neville. "Everything we do is centered on funding crucial pediatric research, as research is the key to the cure."

Rallying Around Research

Through the support of community partners, donations, and community events, CHF recruits exceptional doctors for pediatric research that has positively impacted the lives of many children. For one mother located in Enid, this research saved her newborn baby's life. After she went home from the hospital, her child couldn't keep milk down while breastfeeding and was showing signs of malnutrition. CHF had a crucial piece of equipment that allowed the mother to receive DNA testing results within 24 hours rather than the typical two to three weeks. She discovered her baby had galactosemia, which involves the inability to break down the galactose in milk. She was advised to stop breastfeeding immediately, saving her baby's life.

Currently, Neville and the rest of the board are looking to the future, seeking ways to increase funding and support for future pediatric programming and research opportunities. Because of this dedication, no child is ever turned away from CHF's supported programs, regardless of their ability to pay.

"We have been very blessed with a wonderful, motivated staff who are here for the cause," says Neville. "If you don't constantly reinvest in your research, pediatric care could be set back, and we aren't OK with those ramifications. My favorite part of what we do is interacting with children and their families and positively impacting their life."

Contact Information

Kathy McCracken
childrenshealthfoundation@chfkids.com
405-384-4446

.

SOURCE: Children's Health Foundation



View the original press release on accesswire.com

© 2024 ACCESS Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.